Factor Bioscience Successfully Defends Three U.S. Patents Co

-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lympho

Related Keywords

United States , Massachusetts , Cambridge , Cambridgeshire , United Kingdom , Christopher Rohde , Wilson Sonsini Goodrich Rosati , Matt Angel , Trademark Office , Factor Bioscience Inc , Technology Officer , Bioscience Inc , United States Patent , Chief Technology , Wilson Sonsini Goodrich ,